Cita APA

Riccio, G., Coppola, C., Piscopo, G., Capasso, I., Maurea, C., Esposito, E., . . . Maurea, N. (2016). Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies? Hum Vaccin Immunother.

Chicago Style Citation

Riccio, Gennaro, Carmela Coppola, Giovanna Piscopo, Immacolata Capasso, Carlo Maurea, Emanuela Esposito, Claudia De Lorenzo, i Nicola Maurea. "Trastuzumab and Target-therapy Side Effects: Is Still Valid to Differentiate Anthracycline Type I From Type II Cardiomyopathies?" Hum Vaccin Immunother 2016.

Cita MLA

Riccio, Gennaro, et al. "Trastuzumab and Target-therapy Side Effects: Is Still Valid to Differentiate Anthracycline Type I From Type II Cardiomyopathies?" Hum Vaccin Immunother 2016.